Utilizing Amide Proton Transfer Technique to Characterise Diffuse Gliomas Based on WHO 2021 Classification of CNS Tumors

This dataset includes raw neuroimaging data from the "Utilizing Amide Proton Transfer Technique to Characterize Diffuse Gliomas Based on WHO 2021 Classification of CNS Tumors" study, collected at Federal Neurosurgical Center, Novosibirsk, Russia.
Data were collected in 2023. Participants were adults with diagnosed diffuse brain gliomas. Protocol details can be found at https://medrxiv.org/cgi/content/short/2023.08.24.23294427v1.
MRI data were collected before surgery.
Scanning involved pre- and post-contrast 3D_TFE, 3D_T2w, 3D-FLAIR, SWI, ASL, APT, and DWI. Anatomical scans were defaced using pydeface.

本数据集包含来自一项基于世界卫生组织（WHO）2021版中枢神经系统（CNS）肿瘤分类、利用酰胺质子转移技术（Amide Proton Transfer Technique）表征弥漫性胶质瘤的研究的原始神经影像数据，该研究于俄罗斯新西伯利亚的联邦神经外科中心（Federal Neurosurgical Center）开展。本数据集采集于2023年，研究对象为经确诊的成人弥漫性脑胶质瘤患者。研究方案细节可查阅链接：https://medrxiv.org/cgi/content/short/2023.08.24.23294427v1。磁共振成像（MRI）数据均采集于手术前。扫描序列涵盖对比剂注射前及注射后的3D_TFE序列、3D_T2加权（3D_T2w）序列、3D液体衰减反转恢复（3D-FLAIR）序列、磁敏感加权成像（SWI）、动脉自旋标记（ASL）、酰胺质子转移（APT）序列以及弥散加权成像（DWI）。解剖影像已通过pydeface工具完成面部去标识化处理。